Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Southern African Journal of HIV Medicine
|
February 8, 2023
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence
Michael T Boswell, Tshegofatso Maimela, Dan Hameiri-Bowen, et al.
Frontiers in Immunology
|
August 21, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
Boitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, et al.
Tuberculosis (Edinburgh, Scotland)
|
December 6, 2018
Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting
Yuri F van der Heijden, Fareed Abdullah, Bruno B Andrade, et al.
The Journal of Infection
|
January 9, 2026
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease
Rofhiwa Nesamar, Carol Crowther, Dexter T Chiveto, et al.
Journal of Virology
|
July 2, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity
Simone I Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Cell Reports. Medicine
|
January 5, 2023
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
Simone I Richardson, Prudence Kgagudi, Nelia P Manamela, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Southern African Journal of HIV Medicine
|
February 8, 2023
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence
Michael T Boswell, Tshegofatso Maimela, Dan Hameiri-Bowen, et al.
Frontiers in Immunology
|
August 21, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
Boitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, et al.
Tuberculosis (Edinburgh, Scotland)
|
December 6, 2018
Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting
Yuri F van der Heijden, Fareed Abdullah, Bruno B Andrade, et al.
The Journal of Infection
|
January 9, 2026
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease
Rofhiwa Nesamar, Carol Crowther, Dexter T Chiveto, et al.
Journal of Virology
|
July 2, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity
Simone I Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Cell Reports. Medicine
|
January 5, 2023
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
Simone I Richardson, Prudence Kgagudi, Nelia P Manamela, et al.
Page
of 4